InspireMD Inc - Research Results Supporting the Application for Pre-Market Approval (PMA) from the US Food and Drug Administration in the second half of 2024
InspireMD Inc-支持2024年下半年向美国食品药品管理局申请上市前批准（PMA）的研究结果
InspireMD Inc - Research Results Supporting the Application for Pre-Market Approval (PMA) from the US Food and Drug Administration in the second half of 2024
The translation is provided by third-party software.
The above content is for informational or educational purposes only and does not constitute any investment advice related to Futu. Although we strive to ensure the truthfulness, accuracy, and originality of all such content, we cannot guarantee it.